Fingerprint
Dive into the research topics of 'Evaluation of ifosfamide plus mesna as first-line chemotherapy in women with metastatic breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Evaluation of ifosfamide plus mesna as first-line chemotherapy in women with metastatic breast cancer
J. N. Ingle, J. E. Krook, J. A. Mailliard, L. C. Hartmann, H. S. Wieand
Research output: Contribution to journal › Article › peer-review
7
Scopus
citations